Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Social Anxiety Disorder: later-stage trial registry
18 of 33 indexed Social Anxiety Disorder trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #463 of 28,707 conditions by registered trial count.
33 US clinical trials · 18 currently recruiting · #463 of 28,707 conditions by registered trial count
Social Anxiety Disorder: 33 US clinical trials tracked, 18 recruiting.
Social Anxiety Disorder is the subject of 33 registered US clinical trials on ClinicalTrials.gov, 18 of them currently open to new participants. 7 are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most active sponsor is Georgetown University, running 3 of these trials.
Enrollment posture brief
Registry condition social-anxiety-disorder
OPEN 18 | RECR 55% | LATE 7 | EARLY 4 | RANK #463 | SPON 3
Volume-matched condition peers
Nearest open-share peer: Advanced Ovarian Carcinoma (55% recruiting · 11 trials)
Social Anxiety Disorder lists 18 open slots (55% of 33 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Social Anxiety Disorder on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Social Anxiety Disorder is recruiting above its size-band peers.
18 of 33 indexed trials (54.5%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Social Anxiety Disorder trials is spread across many organizations.
Georgetown University accounts for 3 of 33 trials (9.1%). 29 distinct sponsors appear on at least one study for this condition label.
-
Typical Social Anxiety Disorder enrolment sits around 97 participants.
Median target enrolment is 97 among the 33 trials that report a genuine target (sentinel values excluded). 17 of those (51.5%) plan for fewer than 100 participants.
-
Social Anxiety Disorder research is mostly interventional.
33 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
33 total, page 1 of 1
CO2 Reactivity as a Biomarker of Non-Response to Exposure-Based Therapy
University of Texas at Austin
NCT05467683
P3b Short-term Study of CTN in Patients With ADHD and Comorbid Anxiety
Otsuka Pharmaceutical Development & Commercialization
NCT06973577
Comparing TBT to Disorder-Specific Psychotherapy in Veterans With Social Anxiety Disorder
VA Office of Research and Development
NCT05858346
Validating an Autonomous Interactive Internet-Based Delivery of an Empirically Supported Cognitive Behavioral Therapy for Comorbidity
University of Minnesota
NCT05117255
Neural Markers of Treatment Mechanisms and Prediction of Treatment Outcomes in Social Anxiety
Boston University Charles River Campus
NCT05683223
Group Exposure Workshops for Socially Anxious Undergraduates
University of Colorado, Boulder
NCT06673407
Respiratory Training in the Treatment of Transdiagnostic Pathological Anxiety
University of Texas at Austin
NCT05427708
Individual Factors of CBT Underlying Success
University of Washington
NCT06678295
Internet-delivered Cognitive-Behavioral Therapy for Adolescents With Autism and Anxiety
Baylor College of Medicine
NCT06537128
Neurofeedback Enhanced Cognitive Reappraisal Training - Phase 4
University of Michigan
NCT06563310
Very Brief Exposure: Development of a Novel Exposure Modality for Social Anxiety Disorder in Transition-Age Youth
Children's Hospital Los Angeles
NCT06526260
Mindful Self-compassion for Anxiety and Depression: Impact of Delivery Method
Georgetown University
NCT07028216
A Clinical Trial to Assess the Efficacy, Safety, and Tolerability of a Repeat Dose of Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder
VistaGen Therapeutics
NCT06809179
Targeting Social Function in Anxiety and Eating Disorders
University of Texas Southwestern Medical Center
NCT06198023
Attention Bias Modification Training for Social Phobia (ABMSP)
University of Wisconsin, Milwaukee
NCT06054386
Using TMS to Understand Neural Processes of Social Motivation
Auburn University
NCT06274112
Application of Virtual Reality Technology to Treatment of Social Anxiety
The University of Texas Health Science Center, Houston
NCT06845488
Mindful Self-Compassion for Anxiety Disorders and Depression
Georgetown University
NCT05671419
Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-3)
VistaGen Therapeutics
NCT06358651
Building an Outcomes Assessment Infrastructure to Assess Anxiety Treatment
Mclean Hospital
NCT02305537
Efficacy of BNC210 in Acute, As-needed Treatment of Anxiety in Social Anxiety Disorder - 1
Bionomics Limited
NCT06510504
Cannabidiol (CBD) for the Treatment of Social Anxiety Disorder
EmpowerPharm
NCT05600114
Effects of Therapeutic Mobile Game on Anxiety
Hunter College of City University of New York
NCT05240794
Adding Cognitive Behavioral Therapy to Drug Treatment for Social Anxiety Disorder
Temple University
NCT00074802
Virtual Reality Exposure Therapy for the Treatment of Social Phobia
Georgia State University
NCT02379949
Computerized Treatment for Social Anxiety
Florida State University
NCT03101553
Effect of Oxytocin Nasal Sprays on Social Behavior in Social Anxiety Disorder
Stefan G. Hofmann
NCT01856530
Cannabidiol as a Treatment for Social Anxiety Disorder (R61)
NYU Langone Health
NCT05571592
Study To Evaluate The Effects Of Gabitril™ In Patients With Social Anxiety Disorder
Emory University
NCT00208741
Effect of Mindfulness Meditation on Physiological Response to Unpredictable Stimuli
Georgetown University
NCT03206437
Efficacy of Virtual Reality Exposure Therapy Scripts for Social Phobia
Penn State University
NCT04850989
Adjunctive Quetiapine in the Treatment of Refractory Social Anxiety Disorder in Adults
Cambridge Health Alliance
NCT01224067
Yohimbine to Enhance Cognitive Behavioral Therapy (CBT) for Social Anxiety
Southern Methodist University
NCT00958880
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 3 |
| Phase 3 | 5 |
| Phase 4 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Social Anxiety Disorder records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Social Anxiety Disorder trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Social Anxiety Disorder page
33 registered trials, 18 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 18 Social Anxiety Disorder trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Georgetown University sponsors the most Social Anxiety Disorder trials on record, review their full trial history before evaluating a specific study. See Georgetown University's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Social Anxiety Disorder condition card totals 33 registered trials; most-linked intervention Placebo; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.